Growth Metrics

Eli Lilly (LLY) Assets Growth (5y) (2014 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 20.01%
Dec 31, 2025 19.25%
Sep 30, 2025 21.20%
Jun 30, 2025 19.18%
Mar 31, 2025 16.81%
Dec 31, 2024 14.91%
Sep 30, 2024 14.82%
Jun 30, 2024 13.20%
Mar 31, 2024 10.97%
Dec 31, 2023 7.83%
Sep 30, 2023 5.35%
Jun 30, 2023 5.29%
Mar 31, 2023 3.69%
Dec 31, 2022 1.93%
Sep 30, 2022 1.99%
Jun 30, 2022 2.82%
Mar 31, 2022 4.51%
Dec 31, 2021 4.69%
Sep 30, 2021 5.09%
Jun 30, 2021 5.56%
Mar 31, 2021 6.19%
Dec 31, 2020 5.57%
Sep 30, 2020 3.89%
Jun 30, 2020 3.09%
Mar 31, 2020 2.89%
Dec 31, 2019 1.59%
Sep 30, 2019 1.81%
Jun 30, 2019 2.00%
Mar 31, 2019 1.80%
Dec 31, 2018 4.49%
Sep 30, 2018 5.61%
Jun 30, 2018 4.98%
Mar 31, 2018 6.55%
Dec 31, 2017 5.51%
Sep 30, 2017 4.62%
Jun 30, 2017 5.18%
Mar 31, 2017 3.14%
Dec 31, 2016 2.89%
Sep 30, 2016 2.61%
Jun 30, 2016 2.16%
Mar 31, 2016 1.82%
Dec 31, 2015 2.79%
Sep 30, 2015 3.96%
Jun 30, 2015 5.39%
Mar 31, 2015 5.56%
Dec 31, 2014 5.74%
Sep 30, 2014 12.89%
Jun 30, 2014 5.39%